{"doi":"10.2217/imt-2021-0316","title":"Clinical Outcomes of Immune Checkpoint Inhibitor Diabetes Mellitus at a Comprehensive Cancer Center","abstract":"Introduction: Immune checkpoint inhibitor-associated diabetes mellitus (ICI-DM) is a rare adverse event. In this study, we characterize clinical outcomes of patients with ICI-DM and evaluate survival impact of this complication on melanoma patients. Research design & methods: We conducted a retrospective review of 76 patients diagnosed with ICI-DM from April 2014 to December 2020. Results: 68% of patients presented in diabetic ketoacidosis, 16% had readmissions for hyperglycemia, and hypoglycemia occurred in 70% of patients after diagnosis. Development of ICI-DM did not impact overall survival or progression-free survival in melanoma patients. Conclusion: Development of ICI-DM is associated with long-term insulin dependence and pancreatic atrophy; the use of diabetes technology in this patient population can help improve glycemic control.","journal":"Immunotherapy","year":2023,"id":338233,"datarank":0.6097436519463315,"base_score":2.9444389791664403,"endowment":2.9444389791664403,"self_citation_contribution":0.44166584687496613,"citation_network_contribution":0.16807780507136544,"self_endowment_contribution":0.44166584687496613,"citer_contribution":0.16807780507136544,"corpus_percentile":null,"corpus_rank":null,"citation_count":18,"citer_count":12,"citers_with_citation_signal":7,"citers_with_endowment":7,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.6808,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1070662,"name":"Priyanka Iyer","orcid":"0000-0003-4863-5585","position":1,"is_corresponding":false},{"id":1071167,"name":"Conor Best","orcid":null,"position":2,"is_corresponding":false},{"id":1070663,"name":"Victor Lavis","orcid":"0000-0002-1422-4764","position":3,"is_corresponding":false},{"id":876235,"name":"Jeena Varghese","orcid":"0000-0001-5728-5682","position":4,"is_corresponding":false},{"id":296138,"name":"Sireesha Yedururi","orcid":"0000-0001-6391-3446","position":5,"is_corresponding":false},{"id":1070664,"name":"Veronica Brady","orcid":"0000-0002-9755-3482","position":6,"is_corresponding":false},{"id":90458,"name":"I. C. Glitza","orcid":"0000-0002-4530-7765","position":7,"is_corresponding":false},{"id":723301,"name":"Ramona Dadu","orcid":"0000-0002-3776-208X","position":8,"is_corresponding":false},{"id":543101,"name":"Denái R. Milton","orcid":null,"position":9,"is_corresponding":false},{"id":310388,"name":"Kristy K. Brock","orcid":"0000-0001-9364-5040","position":10,"is_corresponding":false},{"id":1070665,"name":"Sonali Thosani","orcid":"0000-0002-4149-3572","position":11,"is_corresponding":false},{"id":520822,"name":"Rebecca Jeun","orcid":"0000-0002-8305-5810","position":0,"is_corresponding":true}],"reference_count":56,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T01:10:35.973121Z","pmid":"37013834","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}